Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Rosai-Dorfman disease differentiated from a posterior mediastinal tumour: a case report.
J Surg Case Rep
July 2024
Department of Breast and General Thoracic Surgery, Naga Municipal Hospital, Wakayama, Kinokawa-City, 649-6414, Japan.
Rosai-Dorfman disease presenting solely with intrathoracic lesions is exceptionally rare. Herein, we report the case of a 53-year-old man presenting with a posterior mediastinal tumour. Computed tomography revealed a 7-cm soft tissue shadow in the posterior mediastinum.
View Article and Find Full Text PDFDysglycemia With Impaired Insulin Secretion After Resection of a High-Molecular-Weight IGF-II-Producing Tumor.
JCEM Case Rep
January 2023
Diabetes Center, Aizawa Hospital, Matsumoto 390-8510, Japan.
Analysis of insulin and related glucoregulatory hormone secretion following high-molecular-weight insulin-like growth factor II (HMW-IGF-II)-releasing tumor excision has never been reported. In a man with chronic hypoglycemia-plasma glucose (PG), 2.1 mmol/L with undetectable serum insulin, less than 7.
View Article and Find Full Text PDFThe Excretion of Cisplatin after Hyperthermic Intrathoracic Chemotherapy.
Cancers (Basel)
October 2023
Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80539 Munich, Germany.
Hyperthermic intrathoracic chemotherapy (HITOC) is an additional intraoperative treatment option within the multimodality therapy of pleural malignancies. A chemotherapy perfusion with high-dose cisplatin is performed over a period of 60 min after surgical cytoreduction to improve local tumour control through the eradication of residual tumour cells. Although HITOC is increasingly used, there is only little scientific evidence about the necessary safety measures after HITOC.
View Article and Find Full Text PDFSMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report.
Diagn Cytopathol
October 2023
Department of Diagnostic Pathology, Kanazawa University Hospital, Kanazawa, Japan.
SMARCB1 (INI1) is one of the switch/sucrose nonfermentable (SWI/SNF) complexes whose loss is associated with several tumors. SMARCB1 (INI1)-deficient intrathoracic neoplasms are extremely rare and known to be highly malignant and lethal. This report presents the case of a patient diagnosed with SMARCB1 (INI1)-deficient intrathoracic neoplasm during chemotherapy for plasma cell myeloma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!